CoChat

Activin A and follistatin in patients with nonalcoholic fatty liver disease

Open access
Polyzos, Stergios A., Kountouras, Jannis, Anastasilakis, Athanasios D., Triantafyllou, Georgios Α., Mantzoros, Christos S. · 2016 · Metabolism
Cited by 36

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective There are limited data on the role of activin A and its binding protein, follistatin, in nonalcoholic fatty liver disease (NAFLD). The main aim was the evaluation of serum activin A and follistatin levels in patients with biopsy-proven NAFLD vs. controls. Methods This was a case-control study. Fifteen patients with nonalcoholic simple steatosis (SS), 16 with steatohepatitis (NASH), and 52 (24 lean and 28 obese) controls were recruited. Activin A and follistatin were measured using ELISA. Results Activin A levels showed a trend towards progressive increase (p=0.010) from the controls (lean: 356±25, 95% CI 305–408; obese 360±20, 95% CI 320–401 pg/ml) to SS (407±28, 95% CI 347–466 pg/ml) and NASH patients (514±70 95% CI 364–664 pg/ml); this association became non-significant after adjusting for adiposity. Follistatin was not different between groups (lean controls: 1.11±0.08, 95% CI 0.95–1.28; obese controls: 1.00±0.07, 95% CI 0.86–1.14; SS: 0.86±0.07, 95% CI 0.70–1.02; NASH: 1.14±0.09, 95% CI 0.90–1.37 ng/ml; p=0.13). Within the NAFLD group of patients, follistatin was associated with NASH independently from activin A, gender and age, a relationship however likely reflecting the effect of adiposity. Conclusions Activin A is higher in patients with NASH than both lean and obese controls. Future clinical studies are needed to confirm and expand these findings, whereas mechanistic studies exploring underlying mechanisms are also warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.metabol.2016.07.009

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 36

Metadata

Authors
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Triantafyllou, G. Α., & Mantzoros, C. S.
Venue
Metabolism
Publisher
Elsevier BV
Published
2016-10
Volume
65
Issue
10
Pages
1550-1558
ISSN
0026-0495 (ISSN-L)
OpenAlex
W2500667229
Cited by
36
References
6
FWCI
2.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activin A and follistatin in patients with nonalcoholic fatty liver disease. https://app.cochat.ai/papers/10.1016/j.metabol.2016.07.009
The paper
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Triantafyllou, G. Α., & Mantzoros, C. S. (2016). Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metabolism. https://doi.org/10.1016/j.metabol.2016.07.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.